World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
144
Citations
96024
World Ranking
1421
National Ranking
829

Massimo Loda publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Massimo Loda sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 669 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Massimo Loda D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Massimo Loda sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 144 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Massimo Loda is affiliated with Cornell University in the United States and has an extensive publication record primarily in the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their research spans various subfields, including Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology, and Infectious Diseases.

Their most cited papers cover important topics related to COVID-19 and cancer biology, with publication venues ranging from prominent medical journals to specialized cancer research outlets. Notable recent publications include:

  • "Targeting potential drivers of COVID-19: Neutrophil extracellular traps," 2020, The Journal of Experimental Medicine
  • "Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome," 2020, Blood
  • "Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention," 2020, Advanced Drug Delivery Reviews
  • "SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19," 2020, Cancer Cell
  • "EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer," 2021, Nature Cancer

The scientist's frequent co-authors highlight ongoing collaborative efforts and include:

  • Luigi Marchionni
  • Hubert Pakula
  • Brian D. Robinson
  • Giuseppe Nicolò Fanelli
  • Lorelei A. Mucci

Massimo Loda has contributed extensively to several key publication venues, frequently appearing in:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Molecular Cancer Research
  • Nature Communications
  • Clinical Cancer Research

Their work covers a range of main topics including:

  • Prostate Cancer Treatment and Research
  • Cancer, Lipids, and Metabolism
  • Cancer Genomics and Diagnostics
  • Prostate Cancer Diagnosis and Treatment
  • Cancer, Hypoxia, and Metabolism
  • Molecular Biology Techniques and Applications
  • Cancer-related molecular mechanisms research

Throughout their career, Massimo Loda has been recognized as a member of the Association of American Physicians.

Best Publications

  • The landscape of somatic copy-number alteration across human cancers

    Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei

  • Integrative clinical genomics of advanced prostate cancer

    Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

    Arindam Bhattacharjee;William G. Richards;Jane Staunton;Cheng Li

  • Gene expression correlates of clinical prostate cancer behavior.

    Dinesh Singh;Phillip G. Febbo;Phillip G. Febbo;Kenneth Ross;Donald G. Jackson

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

  • Multiclass cancer diagnosis using tumor gene expression signatures

    Sridhar Ramaswamy;Pablo Tamayo;Ryan Rifkin;Sayan Mukherjee

  • Methylation of the hMLH1 Promoter Correlates with Lack of Expression of hMLH1 in Sporadic Colon Tumors and Mismatch Repair-defective Human Tumor Cell Lines

    Kane Mf;Loda M;Gaida Gm;Lipman J

  • Targeting potential drivers of COVID-19: Neutrophil extracellular traps.

    Betsy J. Barnes;Jose M. Adrover;Amelia Baxter-Stoltzfus;Alain Borczuk

  • Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome.

    Elizabeth A Middleton;Xue-Yan He;Frederik Denorme;Robert A. Campbell

  • Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

    Loda M;Cukor B;Tam Sw;Lavin P

  • High-throughput oncogene mutation profiling in human cancer

    Roman K. Thomas;Alissa C. Baker;Ralph M. DeBiasi;Ralph M. DeBiasi;Wendy Winckler;Wendy Winckler

  • mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

    Pradip K Majumder;Phillip G Febbo;Phillip G Febbo;Rachel Bikoff;Rachel Bikoff;Raanan Berger;Raanan Berger

  • Genomic correlates of clinical outcome in advanced prostate cancer.

    Wassim Abida;Joanna Cyrta;Joanna Cyrta;Glenn Heller;Davide Prandi

  • Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

    Qianben Wang;Wei Li;Yong Zhang;Xin Yuan

  • Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer

    Robert E. Reiter;Zhennen Gu;Tetsuro Watabe;George Thomas

  • Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1.

    Long Gu;Susan Tseng;Renée M. Horner;Carmen Tam

  • Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.

    Máirín E. McMenamin;Peggy Soung;Sauni Perera;Irving Kaplan

  • Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance

    Sheng Yu Ku;Spencer Rosario;Yanqing Wang;Ping Mu

  • EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

    Kexin Xu;Zhenhua Jeremy Wu;Anna C. Groner;Housheng Hansen He

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

Frequent Co-Authors

Lorelei A. Mucci
Lorelei A. Mucci Harvard University
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
Sabina Signoretti
Sabina Signoretti Brigham and Women's Hospital
Meir J. Stampfer
Meir J. Stampfer Harvard University
Kathryn L. Penney
Kathryn L. Penney Harvard University
Shuji Ogino
Shuji Ogino Brigham and Women's Hospital
Todd R. Golub
Todd R. Golub Harvard University
Howard D. Sesso
Howard D. Sesso Harvard Medical School
Mark A. Rubin
Mark A. Rubin University of Bern

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always follow a traditional path. Many students start with online degrees or certifications that open doors to different roles in healthcare. For example, earning a medical coding certification cost can be a practical entry point into the medical field, offering flexibility and affordability compared to more comprehensive medical programs.

For those interested in direct patient care, online nursing programs are a popular choice. There are many cheap online nursing programs available that provide essential clinical knowledge and skills while keeping tuition costs lower. After earning a basic nursing degree, advancing to become a nurse practitioner is possible through most affordable nurse practitioner programs available online.

If higher academic achievement is your goal, options like an online phd in nursing can prepare you for leadership, research, or teaching roles in healthcare. Exploring these related online degrees can help you find a pathway that matches your interests, goals, and budget.

Best Scientists Citing Massimo Loda

Trending Scientists

Recently Published Articles